Interestingly, USP15 amplification is reported in certain cancers [20], and here we show this is also the case for lung cancer, where elevated USP15 is associated with worse prognosis in clinical lung adenocarcinoma (Fig. 9). This evidence concerns the gene USP15 and cancer.